The move comes after the World Health Organization halted clinical trials of the drug as a treatment, citing a study that found no benefit and a higher mortality rate for hospitalized patients. A box of hydroxychloroquine, under the brand name Plaquenil, is seen in a pharmacy in Paris.

The move comes after the World Health Organization halted clinical trials of the drug as a treatment, citing a study that found no benefit and a higher mortality rate for hospitalized patients. A box of hydroxychloroquine, under the brand name Plaquenil, is seen in a pharmacy in Paris.